£76.38

Springer Genetic Susceptibility to Cancer: 79 (Developments in Oncology, 79)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£76 today · previous high £76 · all-time low £59

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£76.38 £57.44 £61.57 £65.70 £69.84 £73.97 £78.10 08 March 2026 30 March 2026 21 April 2026 13 May 2026 05 June 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
80 days 10 days · current 0 20 40 60 80 £59 £76 Days at Price

Price Analysis

Most common price: £59 (80 days, 88.9%)

Price range: £59 - £76

Price levels: 2 different prices over 90 days

Description

Despite recent progress in many areas of treatment and control, cancer remains a frightening threat to everyone. While scientists have known for decades that the majority of human cancers are caused by environmental agents such as radiation and the chemicals in cigarette smoke, not everyone who smokes gets lung cancer. Furthermore, many people who assiduously avoid all possible risk from smoking, diet, and pollution still succumb to some form of cancer later in life. Does this mean that there is an element of blind chance in the underlying mechanisms of human carcinogenesis? To what extent do genetic influences play a role in determining the cancer risk of individuals? A number of `cancer families', in which several closely related individuals have suffered from various specific forms of cancer, have been studied by genetic epidemiologists. However, for the majority of cancer cases, little or no discernible genetic influence or family history is found. Recent research has discovered that for many of these `sporadic' (non-familial) cancer cases, defects or aberrations in certain metabolic genes not previously associated with genetic cancer risk may contribute to either causing the disease or at least increasing the chances of developing cancer. It is therefore possible that much of what has previously passed for `bad luck' may turn out to be a new type of `bad genes'. Genetic Susceptibility to Cancer explains that this new idea of `bad genes' may contain an unexpected positive side. The carcinogenic effects of these metabolic genes, unlike those of the oncogenes and tumor suppressor genes that are responsible for the inherited cancer syndromes, can potentially be overcome or nullified. Genetic Susceptibility to Cancer will provide a valuable reference for health professionals, researchers, clinicians and biomedical scientists who are interested in the current thinking in this critically important area of cancer management.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
02 November 2012
Listed Since
03 March 2013

Barcode

No barcode data available

Similar Products You Might Like

Genetics of Colorectal Cancer (Cancer Genetics)
85% match

Genetics of Colorectal Cancer (Cancer Genetics)

Springer

£107.98 29 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
84% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.87 24 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
83% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 19 May 2026
Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications
83% match

Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications

Springer

£136.92 28 May 2026
Male Reproductive Cancers: Epidemiology, Pathology and Genetics (Cancer Genetics)
83% match

Male Reproductive Cancers: Epidemiology, Pathology and Genetics (Cancer Genetics)

Springer

£143.02 02 Jun 2026
Cancer Genetics for the Clinician: Proceedings of the Symposium Cancer Genetics for the Clinican, Held in March 6-8, 1998, in Clearwater Beach, Florida
83% match

Cancer Genetics for the Clinician: Proceedings of the Symposium Cancer Genetics for the Clinican, Held in March 6-8, 1998, in Clearwater Beach, Florida

Springer

£79.08 01 Jun 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
82% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.98 29 May 2026
Oncogenes and Tumor Suppressor Genes in Human Malignancies: 63 (Cancer Treatment and Research, 63)
82% match

Oncogenes and Tumor Suppressor Genes in Human Malignancies: 63 (Cancer Treatment and Research, 63)

Springer

£161.68 05 Jun 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
82% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Principles of Cancer Genetics
82% match

Principles of Cancer Genetics

Springer

£64.99 05 Jun 2026
Molecular Pathogenesis of Colorectal Cancer
82% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£107.98 28 May 2026
Chromosomal Translocations and Genome Rearrangements in Cancer
82% match

Chromosomal Translocations and Genome Rearrangements in Cancer

Springer

£129.58 31 May 2026
Spotlight on Familial and Hereditary Gastric Cancer
81% match

Spotlight on Familial and Hereditary Gastric Cancer

Springer

£113.09 26 May 2026
Gene Regulation and Therapeutics for Cancer
81% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£69.94 20 May 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
81% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£121.32 05 Jun 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
81% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£107.98 28 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
81% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£88.17 06 Jun 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
81% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 31 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
80% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 25 May 2026
Carcinogenesis: 67 (Current Topics in Pathology, 67)
80% match

Carcinogenesis: 67 (Current Topics in Pathology, 67)

Springer

£77.30 24 May 2026
Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)
80% match

Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)

Springer

£85.52 26 May 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
80% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£141.86 31 May 2026
Environment and Breast Cancer
80% match

Environment and Breast Cancer

Springer

£107.98 06 Jun 2026
Epigenetic Alterations in Oncogenesis
80% match

Epigenetic Alterations in Oncogenesis

Springer

£107.98 27 May 2026